Detection of heterozygous truncating mutations in the BRCA1 and APC genes by using a rapid screening assay in yeast

Chikashi Ishioka, Takao Suzuki, Michael Fitzgerald, Michael Krainer, Hideki Shimodaira, Akira Shimada, Tadashi Nomizu, Kurt J. Isselbacher, Daniel Haber, Ryunosuke Kanamaru

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

The detection of inactivating mutations in tumor suppressor genes is critical to their characterization, as well as to the development of diagnostic testing. Most approaches for mutational screening of germ-line specimens are complicated by the fact that mutations are heterozygous and that missense mutations are difficult to interpret in the absence of information about protein function. We describe a novel method using Saccharomyces cerevisiae for detecting protein-truncating mutations in any gene of interest. The PCR-amplified coding sequence is inserted by homologous recombination into a yeast URA3 fusion protein, and transformants are assayed for growth in the absence of uracil. The high efficiency of homologous recombination in yeast ensures that both alleles are represented among transformants and achieves separation of alleles, which facilitates subsequent nucleotide sequencing of the mutated transcript. The specificity of translational initiation of the URA3 gene leads to minimal enzymatic activity in transformants harboring an inserted stop codon, and hence to reliable distinction between specimens with wild-type alleles and those with a heterozygous truncating mutation. This yeast-based stop codon assay accurately detects heterozygous truncating mutations in the BRCA1 gene in patients with early onset of breast cancer and in the APC gene in patients with familial adenomatous polyposis. This approach offers a rapid and reliable method for genetic diagnosis in individuals at high risk for germ- line mutations in cancer susceptibility genes.

Original languageEnglish
Pages (from-to)2449-2453
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume94
Issue number6
DOIs
Publication statusPublished - Mar 18 1997
Externally publishedYes

Fingerprint

APC Genes
BRCA1 Gene
Yeasts
Mutation
Terminator Codon
Homologous Recombination
Alleles
Saccharomyces cerevisiae Proteins
Adenomatous Polyposis Coli
Uracil
Germ-Line Mutation
Neoplasm Genes
Missense Mutation
Tumor Suppressor Genes
Germ Cells
Genes
Proteins
Nucleotides
Breast Neoplasms
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Detection of heterozygous truncating mutations in the BRCA1 and APC genes by using a rapid screening assay in yeast. / Ishioka, Chikashi; Suzuki, Takao; Fitzgerald, Michael; Krainer, Michael; Shimodaira, Hideki; Shimada, Akira; Nomizu, Tadashi; Isselbacher, Kurt J.; Haber, Daniel; Kanamaru, Ryunosuke.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 94, No. 6, 18.03.1997, p. 2449-2453.

Research output: Contribution to journalArticle

Ishioka, Chikashi ; Suzuki, Takao ; Fitzgerald, Michael ; Krainer, Michael ; Shimodaira, Hideki ; Shimada, Akira ; Nomizu, Tadashi ; Isselbacher, Kurt J. ; Haber, Daniel ; Kanamaru, Ryunosuke. / Detection of heterozygous truncating mutations in the BRCA1 and APC genes by using a rapid screening assay in yeast. In: Proceedings of the National Academy of Sciences of the United States of America. 1997 ; Vol. 94, No. 6. pp. 2449-2453.
@article{4e74125c797a4225a450c8bd184c36d1,
title = "Detection of heterozygous truncating mutations in the BRCA1 and APC genes by using a rapid screening assay in yeast",
abstract = "The detection of inactivating mutations in tumor suppressor genes is critical to their characterization, as well as to the development of diagnostic testing. Most approaches for mutational screening of germ-line specimens are complicated by the fact that mutations are heterozygous and that missense mutations are difficult to interpret in the absence of information about protein function. We describe a novel method using Saccharomyces cerevisiae for detecting protein-truncating mutations in any gene of interest. The PCR-amplified coding sequence is inserted by homologous recombination into a yeast URA3 fusion protein, and transformants are assayed for growth in the absence of uracil. The high efficiency of homologous recombination in yeast ensures that both alleles are represented among transformants and achieves separation of alleles, which facilitates subsequent nucleotide sequencing of the mutated transcript. The specificity of translational initiation of the URA3 gene leads to minimal enzymatic activity in transformants harboring an inserted stop codon, and hence to reliable distinction between specimens with wild-type alleles and those with a heterozygous truncating mutation. This yeast-based stop codon assay accurately detects heterozygous truncating mutations in the BRCA1 gene in patients with early onset of breast cancer and in the APC gene in patients with familial adenomatous polyposis. This approach offers a rapid and reliable method for genetic diagnosis in individuals at high risk for germ- line mutations in cancer susceptibility genes.",
author = "Chikashi Ishioka and Takao Suzuki and Michael Fitzgerald and Michael Krainer and Hideki Shimodaira and Akira Shimada and Tadashi Nomizu and Isselbacher, {Kurt J.} and Daniel Haber and Ryunosuke Kanamaru",
year = "1997",
month = "3",
day = "18",
doi = "10.1073/pnas.94.6.2449",
language = "English",
volume = "94",
pages = "2449--2453",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "6",

}

TY - JOUR

T1 - Detection of heterozygous truncating mutations in the BRCA1 and APC genes by using a rapid screening assay in yeast

AU - Ishioka, Chikashi

AU - Suzuki, Takao

AU - Fitzgerald, Michael

AU - Krainer, Michael

AU - Shimodaira, Hideki

AU - Shimada, Akira

AU - Nomizu, Tadashi

AU - Isselbacher, Kurt J.

AU - Haber, Daniel

AU - Kanamaru, Ryunosuke

PY - 1997/3/18

Y1 - 1997/3/18

N2 - The detection of inactivating mutations in tumor suppressor genes is critical to their characterization, as well as to the development of diagnostic testing. Most approaches for mutational screening of germ-line specimens are complicated by the fact that mutations are heterozygous and that missense mutations are difficult to interpret in the absence of information about protein function. We describe a novel method using Saccharomyces cerevisiae for detecting protein-truncating mutations in any gene of interest. The PCR-amplified coding sequence is inserted by homologous recombination into a yeast URA3 fusion protein, and transformants are assayed for growth in the absence of uracil. The high efficiency of homologous recombination in yeast ensures that both alleles are represented among transformants and achieves separation of alleles, which facilitates subsequent nucleotide sequencing of the mutated transcript. The specificity of translational initiation of the URA3 gene leads to minimal enzymatic activity in transformants harboring an inserted stop codon, and hence to reliable distinction between specimens with wild-type alleles and those with a heterozygous truncating mutation. This yeast-based stop codon assay accurately detects heterozygous truncating mutations in the BRCA1 gene in patients with early onset of breast cancer and in the APC gene in patients with familial adenomatous polyposis. This approach offers a rapid and reliable method for genetic diagnosis in individuals at high risk for germ- line mutations in cancer susceptibility genes.

AB - The detection of inactivating mutations in tumor suppressor genes is critical to their characterization, as well as to the development of diagnostic testing. Most approaches for mutational screening of germ-line specimens are complicated by the fact that mutations are heterozygous and that missense mutations are difficult to interpret in the absence of information about protein function. We describe a novel method using Saccharomyces cerevisiae for detecting protein-truncating mutations in any gene of interest. The PCR-amplified coding sequence is inserted by homologous recombination into a yeast URA3 fusion protein, and transformants are assayed for growth in the absence of uracil. The high efficiency of homologous recombination in yeast ensures that both alleles are represented among transformants and achieves separation of alleles, which facilitates subsequent nucleotide sequencing of the mutated transcript. The specificity of translational initiation of the URA3 gene leads to minimal enzymatic activity in transformants harboring an inserted stop codon, and hence to reliable distinction between specimens with wild-type alleles and those with a heterozygous truncating mutation. This yeast-based stop codon assay accurately detects heterozygous truncating mutations in the BRCA1 gene in patients with early onset of breast cancer and in the APC gene in patients with familial adenomatous polyposis. This approach offers a rapid and reliable method for genetic diagnosis in individuals at high risk for germ- line mutations in cancer susceptibility genes.

UR - http://www.scopus.com/inward/record.url?scp=12644303219&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12644303219&partnerID=8YFLogxK

U2 - 10.1073/pnas.94.6.2449

DO - 10.1073/pnas.94.6.2449

M3 - Article

C2 - 9122215

AN - SCOPUS:12644303219

VL - 94

SP - 2449

EP - 2453

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 6

ER -